ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 727486 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 727486; 2) Community: the network communities that were significantly associated with the response to NSC 727486; 3) Molecule: the relationships between components within communities and NSC 727486; 4) MDR: the compounds that were significantly associated with the NSC 727486.

NSC Compound Enrichment Correlation
NSC 644259 Null 0.00485717408280862 -0.11097991
NSC 668490 Null 0.00485717408280862 0.24499581
NSC 709358 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol 0.00485717408280862 0.11532742
NSC 711077 Null 0.00485717408280862 -0.049394236
NSC 718564 Null 0.00485717408280862 -0.047202836
NSC 720497 Null 0.00485717408280862 0.0033478971
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.0048681766467277 -0.091330835
NSC 758682 ARTENIMOL 0.0048681766467277 -0.078031227
NSC 109451 Null 0.00486817664672774 0.24858686
NSC 123461 Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) 0.00486817664672774 -0.033466516
Total:101  Current:16    [First] [Prev] [Next] [Last]